DAILYZ HEALTH NEWS

What to know about CDC’s draft guidance on doxy-PEP

March 06, 2024 2 min watch Add topic to email alerts Receive an email when new articles are posted on

March 11, 2024 Evan Vega

Why Covid Patients Who Could Most Benefit From Paxlovid Still Aren’t Getting It

Evangelical minister Eddie Hyatt believes in the healing power of prayer but “also the medical approach.” So on a February

Infectious Disease

March 11, 2024 Evan Vega

Universal syphilis screening program increases testing, diagnoses among pregnant people

March 06, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Pfizer is betting big on cancer drugs after Covid decline

Public Health

March 10, 2024 Evan Vega

Pfizer is betting big on cancer drugs after Covid decline

Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on

Infectious Disease

March 10, 2024 Evan Vega

Investigational two-drug regimen safe, effective for patients with HIV

March 06, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Infectious Disease

March 10, 2024 Evan Vega

Vtama cream achieves consistent efficacy in atopic dermatitis across racial groups

March 09, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

I learned how eating and exercise impact my blood sugar

Public Health

March 10, 2024 Evan Vega

I learned how eating and exercise impact my blood sugar

Ashley Capoot wearing a CGM. Ashley Capoot | CNBC As it turns out, exercise is good for you. So is

Infectious Disease

March 9, 2024 Evan Vega

People who struggle with daily HIV regimen should be offered long-acting injections

March 09, 2024 2 min watch Add topic to email alerts Receive an email when new articles are posted on

Infectious Disease

March 9, 2024 Evan Vega

Four children achieve treatment-free HIV remission for 1 year

March 08, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Eli Lilly Alzheimer's drug FDA approval delayed

Public Health

March 9, 2024 Evan Vega

Eli Lilly Alzheimer’s drug FDA approval delayed

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

Scientists Identify Two Brain Cell Types Behaving Differently in Depression Patients, Paving Way for Targeted Therapies

Abbott Survey Reveals 74% of Americans Believe Chronic Diseases Like Diabetes Are Preventable, Cites Confusion and Costs as Barriers

White House Reclassifies Cannabis as Schedule III Substance, Enabling FDA Research on Medical Uses

New Hampshire Lawmaker Pushes State Coverage for GLP-1 Weight Loss Drugs Like Ozempic

FDA Approves Blood Test for Early Alzheimer’s Risk Detection Using Neutrophil Inflammation Marker

IAS-USA endorses off-label use of long-acting ART for HIV

Why Covid Patients Who Could Most Benefit From Paxlovid Still Aren’t Getting It

Universal syphilis screening program increases testing, diagnoses among pregnant people

Pfizer is betting big on cancer drugs after Covid decline

Investigational two-drug regimen safe, effective for patients with HIV

Vtama cream achieves consistent efficacy in atopic dermatitis across racial groups

I learned how eating and exercise impact my blood sugar

People who struggle with daily HIV regimen should be offered long-acting injections

Four children achieve treatment-free HIV remission for 1 year

Eli Lilly Alzheimer’s drug FDA approval delayed